# FDA Inspection 866422 - Altasciences CDMO Philadelphia, LLC - February 18, 2014

Source: https://www.keypedia.com/records/fda_inspections/altasciences-cdmo-philadelphia-llc/19162ca4-a242-4d61-ad16-04a4a0ffb984
Source feed: FDA_Inspections

> FDA Inspection 866422 for Altasciences CDMO Philadelphia, LLC on February 18, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 866422
- Company Name: Altasciences CDMO Philadelphia, LLC
- Inspection Date: 2014-02-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1244787 - 2024-07-26](https://www.keypedia.com/records/fda_inspections/altasciences-cdmo-philadelphia-llc/3e16708a-431c-4a74-aed3-4d910bcc7e11)
- [FDA Inspection 1081264 - 2018-12-17](https://www.keypedia.com/records/fda_inspections/altasciences-cdmo-philadelphia-llc/5583150f-cbb3-4e06-bbdd-f8f3ce789993)
- [FDA Inspection 716884 - 2011-03-16](https://www.keypedia.com/records/fda_inspections/altasciences-cdmo-philadelphia-llc/cd6cc932-9301-4020-ab08-b8599115dc2c)

Company: https://www.keypedia.com/companies/altasciences-cdmo-philadelphia-llc/26bba634-aabd-494e-9c20-6a3b025a7403

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c